Sec61 and ER Stress in Beta-cell Function and Type 2 Diabetes
Sec61 and ER Stress in Beta-cell Function and Type 2 Diabetes
批准号:
7874668
负责人:
Nicholas Gekakis
金额:
$47.29万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2013-04-30
关键词:
AffectAgeAnimalsApoptosisAutopsyBeta CellCandidate Disease GeneCell DeathCell physiologyCellsDataDefectDevelopmentDiabetes MellitusDiabetic mouseElectron MicroscopyEndoplasmic ReticulumFailureFamilyFunctional disorderGenesGeneticGenetic Predisposition to DiseaseGenetic ScreeningHumanHuman GeneticsInsulin ResistanceLeadLiteratureMapsMolecular ChaperonesMusMutant Strains MiceMutationNatureNon-Insulin-Dependent Diabetes MellitusOxidative StressPancreasPeripheralPharmaceutical PreparationsPhenotypePlayProcessProspective StudiesProtein ImportProtein translocationProteinsRelative (related person)RoleSyndromeTestingTissuesUp-RegulationYeastscytokinedesigndiabeticendoplasmic reticulum stressgenome wide association studyinsulin secretionmouse modelmutantneonatal diabetes mellitusnovelprotein foldingpublic health relevanceresearch studyresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In a phenotype-driven, genetic screen to identify novel genes that affect ¿-cell function, we found a mutation in Sec61a1 in a family of mice with diabetes. Sec61a1 encodes the protein conducting subunit of the endoplasmic reticulum (ER) translocation channel, which is responsible for protein import into the ER. Diabetes in Sec61a1 mutant mice is correlated with ¿-cell apoptosis and massively distended ER. The distended ER is consistent with ER stress, an accumulation of unfolded proteins within the ER. The cell mounts a response to ER stress, the unfolded protein response, which includes up regulation of protein folding chaperones (e.g. Bip), and, in the case that ER stress cannot be relieved, up regulation of the proapoptotic transcription factor Chop. Bip and Chop are both up regulated in diabetic Sec61a1 mutant animals. Thus, our hypothesis is that Sec61a1 mutation leads to ER stress, ¿-cell apoptosis, and diabetes. The experiments in this proposal are designed to test this hypothesis, to understand the mechanism by which Sec61a1 mutation leads to ER stress, and to ask if ER stress plays a role in the ¿-cell dysfunction that is part of type 2 diabetes. PUBLIC HEALTH RELEVANCE: The development of type 2 diabetes (T2D) is a two-hit process involving insulin resistance in peripheral tissues and a failure of pancreatic ¿-cells to compensate for insulin resistance by increased insulin secretion. Prospective studies in humans have established the causative role of both insulin resistance and ¿-cell dysfunction in T2D. What is the nature of the ¿-cell failure that accompanies T2D? Autopsy studies have shown that T2D is associated with a relative decrease in ¿-cell mass due to apoptosis, a finding that has been supported in mouse models. There is evidence in the literature to support any of several mechanisms of ¿-cell loss, including oxidative stress, glucotoxicity, lipotoxicity, and cytokine-induced cell death. In these studies we will examine the role of endoplasmic reticulum (ER) stress and ER stress-induced apoptosis in ¿- cell dysfunction. Evidence for a role of ER stress in ¿-cell death comes from human genetic syndromes marked by neonatal diabetes, and various mouse models including a novel mouse model of diabetes from our own lab. Via a forward genetic approach in the mouse, we have identified a family of diabetic mice with a mutation in the ER translocation channel protein Sec61a1. Preliminary data indicate that the mice become diabetic because they lose ¿-cells beginning at about four weeks of age. This loss correlates with an increase in ER stress. The mechanism of ER stress likely relates to a defect in protein processing or degradation due to the Sec6a1 mutation. The studies described herein seek to exploit this and other mouse models of diabetes to answer some fundamental questions about the nature of ¿-cell dysfunction in T2D. How does this mutation in Sec61a1 lead to ER stress, ¿-cell apoptosis, and diabetes and does ER stress play a role in the ¿- cell dysfunction normally seen in T2D? It is hoped that an increased understanding of ¿-cell dysfunction will lead to more effective drugs against T2D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
QNMR system for whole body composition analysis of live mice
-
批准号:8052229
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2011
-
负责人:Nicholas Gekakis
-
依托单位:
Sec61 and ER Stress in Beta-cell Function and Type 2 Diabetes
-
批准号:8059732
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2009
-
负责人:Nicholas Gekakis
-
依托单位:
Sec61 and ER Stress in Beta-cell Function and Type 2 Diabetes
-
批准号:7652064
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:Nicholas Gekakis
-
依托单位:
Sec61 and ER Stress in Beta-cell Function and Type 2 Diabetes
-
批准号:8270578
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2009
-
负责人:Nicholas Gekakis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: